Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00599703 · ClinicalTrials.gov registry record

Language Function in Patients With Brain Tumors

A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
7
Enrollment target

NCT00599703: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.

NCT00599703 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00599703 has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
7 participants
Enrollment target

Study Summary

The purpose of this study is to use an imaging method called functional magnetic resonance imaging (fMRI) in patients who have a tumor near an area of the brain that is believed to control language. The fMRI is a new kind of imaging that uses a strong magnetic field to look at functioning brain tissue. This kind of imaging will be used to study the effect of the brain tumor on your speech.

Interventions

  • OTHER fMRI Scan, pre- and post language evaluation

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2005-05
Est. Completion 2009-03

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT00599703

The ClinicalTrials.gov registry entry for NCT00599703 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which fMRI Scan, pre- and post language evaluation is the first listed.

NCT00599703 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00599703 about?

NCT00599703 is a clinical study titled "Language Function in Patients With Brain Tumors". The purpose of this study is to use an imaging method called functional magnetic resonance imaging (fMRI) in patients who have a tumor near an area of the brain that is believed to control language. The fMRI is a new kind of imaging that uses a strong magnetic field to look at functioning brain tiss...

What is the current status of trial NCT00599703?

This trial is currently completed. The enrollment target is 7 participants. The study started on 2005-05. Estimated completion is 2009-03.

What interventions are being tested in trial NCT00599703?

The interventions under investigation include: fMRI Scan, pre- and post language evaluation (OTHER).

Who is sponsoring clinical trial NCT00599703?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.